Portal de Periódicos da CAPES

Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies

2019; Wiley; Volume: 120; Issue: 1 Linguagem: Inglês

10.1002/jso.25374

1096-9098

Robert W. Lentz, Al B. Benson, Sheetal Kircher,

Pharmaceutical Economics and Policy

Financial toxicity is the adverse impact of a cancer diagnosis on a patient’s financial well‐being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. This review will summarize the prevalence, causes, and consequences of financial toxicity, with an emphasis on strategies to anticipate and reduce its burden. Improvement will require multilevel, coordinated efforts between stakeholders including patients, providers, health systems, payers, manufacturers, and policymakers.